BioSpace News Archive

The new Dual Syringe Dispenser can accommodate conveniently packaged 50ml side-by-side syringes, in ratios 1:1, 2:1, 4:1 and 10:1.

Today, the Lupus Foundation of America announced the recipients of the 2019 Gary S. Gilkeson Career Development Award (CDA), which will fund research projects focused on scientific and clinical issues impacting the lupus field

Six early-career neuroscience researchers will participate in unique advisory council

Palo Alto Health Sciences, Inc. (PAHS), whose product Freespira® is the only FDA-cleared digital therapeutic for treating panic attacks, panic related disorders, and PTSD is pleased to announce the addition of Joseph (Joe) Perekupka to its Senior Executive team as Chief Commercial Officer

Aperio Clinical Outcomes announced that industry veteran Jennifer Hodak has joined the company as Director of Talent Acquisition as they scale-up to support the growing needs of their pharmaceutical, biotech and medical device client base.

Spherix Incorporated (Nasdaq: SPEX) President and CEO, Anthony Hayes, today released a letter to shareholders outlining the Company’s plans for its previously disclosed dividend distribution.

Evgen Pharma (AIM: EVG) a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that five patients who participated in the STEM trial (“STEM”) received SFX-01 treatment for over one year, with two of these five patients continuing to be treated with SFX-01.

4WEB Medical, an orthopedic device company focused on developing innovative implants utilizing its proprietary Truss Implant Technology™ announced today the completion of Phase I in vitro testing that demonstrates the surface roughness on its truss implants stimulates a superior osteogenic response when compared to smooth titanium and PEEK.

Myelodysplastic syndrome (MDS), one of the most common blood cancers, has very few treatment options.

Leading kidney care innovation company continues rapid nationwide growth